findinEsegui ricerca
Image

Imperial Innovation

Organisation available for the Professional Exchange Call: 4 (27th Oct 2014 - 5th Dec 2014)
Imperial Innovation TTO

Type of organisation: TTO

Website: www.imperialinnovations.co.uk

Stay period: 6 weeks

 

Areas of expertise looked for:

  • TTO structure and management
  • Patenting/IPR management
  • Licensing
  • Contract research
  • Investment analysis
  • Asset selection
  • Technology assessment

Description:

Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London.

Imperial Innovations is a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation, and investment.

Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Originally founded as the technology transfer office for Imperial College London - a role it still carries out today - Innovations also invests in opportunities typically arising from intellectual property developed at, or associated with, the University of Cambridge, the University of Oxford and University College London, in addition to those arising from Imperial College London.

These are the top four research intensive universities in Europe (QS World University Rankings) receiving between them research income of over £1.3 billion per annum. Innovations also acts as the technology transfer office for several NHS Trusts, including Imperial College Healthcare NHS Trust, Royal Brompton and Harefield NHS Foundation Trust and North West London Hospitals NHS Trust.

This project has received funding from the European Union’s Seventh Programme for 
research, technological development and demonstration under grant agreement No 305128
 
  ENTENTE is supported by the European Commission and coordinated by Inserm-Transfert SA